KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (Weighted Average): 2018-2025

Historic Shares Outstanding (Weighted Average) for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $389.1 million.

  • Moderna's Shares Outstanding (Weighted Average) rose 1.22% to $389.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.1 million, marking a year-over-year increase of 1.22%. This contributed to the annual value of $384.8 million for FY2024, which is 0.93% up from last year.
  • Per Moderna's latest filing, its Shares Outstanding (Weighted Average) stood at $389.1 million for Q3 2025, which was up 0.60% from $386.7 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Shares Outstanding (Weighted Average) peaked at $405.4 million during Q4 2021, and registered a low of $380.6 million during Q3 2023.
  • Over the past 3 years, Moderna's median Shares Outstanding (Weighted Average) value was $384.4 million (recorded in 2024), while the average stood at $384.1 million.
  • As far as peak fluctuations go, Moderna's Shares Outstanding (Weighted Average) increased by 8.44% in 2021, and later fell by 5.25% in 2022.
  • Over the past 5 years, Moderna's Shares Outstanding (Weighted Average) (Quarterly) stood at $405.4 million in 2021, then fell by 5.25% to $384.2 million in 2022, then decreased by 0.75% to $381.3 million in 2023, then rose by 0.93% to $384.8 million in 2024, then rose by 1.22% to $389.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $389.1 million in Q3 2025, compared to $386.7 million in Q2 2025 and $385.8 million in Q1 2025.